Results 1 to 10 of about 445,193 (314)
Knowledge, attitude, and practice towards insulin therapy in type 2 diabetes: an insight from Ethiopian context [PDF]
BMC Primary CareBackground As type 2 diabetes is a growing health problem worldwide, targeting an early treatment and intensification of therapy will decrease the associated morbidity and mortality as evidenced by large trials.
Biniyam Woya Sheno +2 more
doaj +2 more sources
Low FT4 levels in early pregnancy are associated with higher insulin therapy need in women with gestational diabetes mellitus [PDF]
European Thyroid JournalObjective: To compare demographical and thyroid parameters/disorders between a group of women with gestational diabetes mellitus (GDM) treated with diet and lifestyle measures (DiLS) and a group also necessitating insulin therapy (IT).
Emna Jelloul +8 more
doaj +2 more sources
Insulin resistance and iatrogenic hyperinsulinemia in type 1 diabetes - norm or complication? Role of metformin in type 1 diabetes mellitus [PDF]
Acta Poloniae Pharmaceutica, 2023 There is a rising trend of overweight and obesity among individuals with type 1 diabetes. This is often associated with decreased insulin sensitivity, increased insulin dose requirements and poor glycemic control.
Małgorzata Bekier +2 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Background: Controversies concerning the association between insulin therapy and atherosclerotic lesions in type 2 diabetes mellitus (T2DM) remain to exist.
Jiang-Feng Ke +5 more
doaj +1 more source
Issues of insulin therapy for type 2 diabetes and ways to solve them
Mìžnarodnij Endokrinologìčnij Žurnal, 2023 The article is a summary of personal experience and literature data from PubMed, Scopus, Web of Science, ClinicalTrials.gov databases. As a result of the analysis, the main problems faced by practical endocrinologists when administering insulin therapy ...
V.I. Katerenchuk, A.V. Katerenchuk
doaj +1 more source
New Insulins and Insulin Therapy [PDF]
Diabetes Technology & Therapeutics, 2013 The introduction of the so-called 'designer' insulins, the insulin analogues, has offered new opportunities in the clinical management of diabetes. Two additional new entities are close to reaching clinical practice. Linjeta™ (formally called VIAject) is not an analogue but rather a different formulation of human insulin which may give it a more rapid ...
Bolinder, Jan +2 more
openaire +7 more sources
Frontiers in Endocrinology, 2023 IntroductionThe purpose of this retrospective clinic chart review study was to determine the potential of a combination therapy (CT) consisting of γ-aminobutyric acid (GABA), a dipeptidyl peptidase-4 inhibitor (DPP-4i), and a proton pump inhibitor (PPI ...
Alexander Rabinovitch +9 more
doaj +1 more source
The future of insulin therapy [PDF]
Diabetes Research and Clinical Practice, 2021 Although insulin therapy was already introduced one-hundred years ago, insulin formulations are still being refined to reduce the risk of hypoglycaemia and of other insulin side effects such as weight gain. This review summarises the available clinical data for some ongoing developments of new insulins and evaluates their potential for future insulin ...
openaire +2 more sources
New Insulins, Biosimilars, and Insulin Therapy [PDF]
Diabetes Technology & Therapeutics, 2016 Exogenous insulin has greatly changed the outlook for patients with diabetes ever since its discovery and isolation. Yet, serious complications can result as patients experience both hyperglycemic and hypoglycemic states, even when they strictly follow an insulin regimen. Several chemically or genetically modified insulins have been developed that tune
Thomas, Danne +2 more
openaire +11 more sources
Type 1 diabetes mellitus in chronic insulin deficiency conditions
Медицинский вестник Юга России, 2021 Mauriac syndrome is a severe complication of type 1 diabetes mellitus, manifested by growth retardation, impaired formation of secondary sexual characteristics, lack of libido, and hepatomegaly. Currently, the presented syndrome is quite rare.
A. Yu. Surovtseva +2 more
doaj +1 more source